Enhancing Tetrahydrocannabinol’s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011

<b>Background/Objectives:</b> Current inflammatory bowel disease (IBD) treatments focus on symptomatic relief, highlighting the need for innovative approaches. Dysregulation of the cannabinoid 1 (CB1) receptor, part of the endocannabinoid system, is linked to colitis. While tetrahydrocannabinol (THC...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dinesh Thapa, Mohan Patil, Leon N Warne, Rodrigo Carlessi, Marco Falasca
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-01-01
coleção:	Pharmaceuticals
Assuntos:	inflammatory bowel disease DSS-induced ulcerative colitis cannabinoid 1 receptor (CB1R) tetrahydrocannabinol (THC) CB1R allosteric modulator ZCZ011
Acesso em linha:	https://www.mdpi.com/1424-8247/18/2/148
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!